Moreover, the MSH2 variant is correlated with the second highest risk of CRC, only slightly lower than MLH1, with cumulative cancer incidences of 46.6% (females) and 51.4% (males) among individuals aged 75 [20]. The gene discussed is MLH1; the disease is cancer.